Detalles de la búsqueda
1.
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Clin Exp Immunol
; 202(3): 353-362, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757277
Resultados
1 -
1
de 1
1
Próxima >
>>